Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
- Tunitas Therapeutics
- 409 Illinois Street
- San Francisco CA, 94158
- UNITED STATES
Tunitas Therapeutics is a privately held biopharmaceutical company that is developing targeted protein therapeutics. Tunitas’ proteins are capable of altering the natural course of such allergic diseases as food allergies, asthma, rhinitis and atopic dermatitis. The company’s therapeutic approach offers the potential for long-lasting treatments. Tunitas is also developing a next-generation immunotherapy platform of fusion proteins which offer the prospect of long-term relief for specific allergic diseases.